OTC Regulation for the Buyside - A Closer Look

Download Now:

There has been much speculation about the challenges which new OTC Regulation will bring in the months to come, mainly:

How will pending regulation affect my business?
Are the systems I have in place enough to keep me compliant?

Join Kevin McPartland, Senior Analyst at TABB Group, with John Avery and Scott Alintoff from SunGard, as they discuss:

  • What does the current landscape look like across the buy-side and sell-side?
  • What will the impacts be on my business?
  • What do I need to consider in terms of technology & operations support?
  • The potential changes to the OTC derivative lifecycle and how those events translate into VPM
  • SunGard’s readiness to respond to clients’ needs based on these changes

A recording of this webinar is now available for download. Please enter your details below to download this webinar.

*
*
*
*
*
*